Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rubbert-Roth

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Dermatology|November 8, 2021
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinibL Joos, F Vetterli, T Jaeger, et al.
Zeitschrift Fur Rheumatologie|November 20, 2010
[§ 116b SGB V (social insurance code, book five) for rheumatology patients. An empirical assessment on the basis of administrative data]T Rath, E Bokern, E Sefo-Bukow, et al.
Annals of the Rheumatic Diseases|December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)Gerd R Burmester, E Feist, H Kellner, et al.
Annals of the Rheumatic Diseases|October 13, 2010
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trialP P Tak, W F Rigby, A Rubbert-Roth, et al.
Zeitschrift Fur Rheumatologie|March 5, 2014
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]I H Tarner, K Albrecht, M Fleck, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness studyP Emery, J E Gottenberg, A Rubbert-Roth, et al.
Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Annals of the Rheumatic Diseases|March 28, 2013
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012Daniel E Furst, Edward Clark Keystone, Alexander K So, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Dermatology|November 8, 2021
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinibL Joos, F Vetterli, T Jaeger, et al.
Zeitschrift Fur Rheumatologie|November 20, 2010
[§ 116b SGB V (social insurance code, book five) for rheumatology patients. An empirical assessment on the basis of administrative data]T Rath, E Bokern, E Sefo-Bukow, et al.
Annals of the Rheumatic Diseases|December 29, 2010
Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)Gerd R Burmester, E Feist, H Kellner, et al.
Annals of the Rheumatic Diseases|October 13, 2010
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trialP P Tak, W F Rigby, A Rubbert-Roth, et al.
Zeitschrift Fur Rheumatologie|March 5, 2014
[Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative]I H Tarner, K Albrecht, M Fleck, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness studyP Emery, J E Gottenberg, A Rubbert-Roth, et al.
Zeitschrift Fur Rheumatologie|October 8, 2011
[Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis]J R Kalden, H Burkhardt, B Buss, et al.
Zeitschrift Fur Rheumatologie|December 19, 2015
[Do we still need clinical studies in rheumatology?]U Henkemeier, R Alten, B Bannert, et al.
Zeitschrift Fur Rheumatologie|August 30, 2012
[German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Adapted EULAR recommendations and updated treatment algorithm]K Krüger, J Wollenhaupt, K Albrecht, et al.
Annals of the Rheumatic Diseases|March 28, 2013
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012Daniel E Furst, Edward Clark Keystone, Alexander K So, et al.
Pageof 4